Procaps Group S.A. logo

Procaps Group S.A.

NASDAQ:PROC

Overview | Financials
Company Name Procaps Group S.A.
Symbol PROC
Currency USD
Price 2.35
Market Cap 265,136,400
Dividend Yield 0%
52-week-range 0.5 - 4.95
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Ruben Minski
Website https://www.procapsgroup.com

An error occurred while fetching data.

About Procaps Group S.A.

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital

Related Stocks

OrthoPediatrics Corp. logo

OrthoPediatrics Corp.

KIDS

22.89 USD

Cerus Corporation logo

Cerus Corporation

CERS

1.56 USD

Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc.

TMCI

6.98 USD

Sharecare, Inc. logo

Sharecare, Inc.

SHCR

1.43 USD

Morphic Holding, Inc. logo

Morphic Holding, Inc.

MORF

56.99 USD

Revance Therapeutics, Inc. logo

Revance Therapeutics, Inc.

RVNC

3.06 USD

National Research Corporation logo

National Research Corporation

NRC

17.43 USD

Varex Imaging Corporation logo

Varex Imaging Corporation

VREX

14.82 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

7.41 USD

Financials

Numbers are in millions USD

Numbers are in millions USD